Praxis Precision Medicines, Inc. (PRAX) shares rallied 183.7% in the last trading session to close at $162.71. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 30.3% gain over the past four weeks.Praxis Precision Medicines shares surged following the announcement of positive topline results from two phase III studies from the Essential3 program of ulixacaltamide for treating essential tremor (ET). Study 1 show ...